Otterness IG - Search Results

1

Isolation and characterization of biologically active murine interleukin-1 alpha derived from expression of a synthetic gene in Escherichia coli.

Daumy GO, Merenda JM, McColl AS, Andrews GC, Franke AE, Geoghegan KF, Otterness IG. Daumy GO, et al. Among authors: otterness ig. Biochim Biophys Acta. 1989 Sep 14;998(1):32-42. doi: 10.1016/0167-4838(89)90115-5. Biochim Biophys Acta. 1989. PMID: 2551391

2

Reduction of biological activity of murine recombinant interleukin-1 beta by selective deamidation at asparagine-149.

Daumy GO, Wilder CL, Merenda JM, McColl AS, Geoghegan KF, Otterness IG. Daumy GO, et al. Among authors: otterness ig. FEBS Lett. 1991 Jan 14;278(1):98-102. doi: 10.1016/0014-5793(91)80093-i. FEBS Lett. 1991. PMID: 1993481 Free article.

3

The effects of continuous administration of murine interleukin-1 alpha in the rat.

Otterness IG, Seymour PA, Golden HW, Reynolds JA, Daumy GO. Otterness IG, et al. Physiol Behav. 1988;43(6):797-804. doi: 10.1016/0031-9384(88)90379-4. Physiol Behav. 1988. PMID: 3266339

4

Role of prostaglandins in the behavioral changes induced by murine interleukin 1 alpha in the rat.

Otterness IG, Golden HW, Seymour PA, Eskra JD, Daumy GO. Otterness IG, et al. Cytokine. 1991 Jul;3(4):333-8. doi: 10.1016/1043-4666(91)90502-5. Cytokine. 1991. PMID: 1873481

5

Effects of continuously administered murine interleukin-1 alpha: tolerance development and granuloma formation.

Otterness IG, Golden HW, Brissette WH, Seymour PA, Daumy GO. Otterness IG, et al. Infect Immun. 1989 Sep;57(9):2742-50. doi: 10.1128/iai.57.9.2742-2750.1989. Infect Immun. 1989. PMID: 2788137 Free PMC article.

6

Inhibiting protein-protein interactions: a model for antagonist design.

Chrunyk BA, Rosner MH, Cong Y, McColl AS, Otterness IG, Daumy GO. Chrunyk BA, et al. Among authors: otterness ig. Biochemistry. 2000 Jun 20;39(24):7092-9. doi: 10.1021/bi000096+. Biochemistry. 2000. PMID: 10852706

7

Determining selectivity of drugs by quantitative two-dimensional gel analysis. A study of tenidap, piroxicam, and dexamethasone.

Otterness IG, Daumy GO, Gollaher MG Jr, Downs JT, Zuzel TJ, Bliven ML, Merenda JM. Otterness IG, et al. Biochem Pharmacol. 1996 Sep 27;52(6):917-25. doi: 10.1016/0006-2952(96)00448-0. Biochem Pharmacol. 1996. PMID: 8781511

8

Identification and characterization of a C-terminally extended form of recombinant murine IL-6.

Danley DE, Strick CA, James LC, Lanzetti AJ, Otterness IG, Grenett HE, Fuller GM. Danley DE, et al. Among authors: otterness ig. FEBS Lett. 1991 May 20;283(1):135-9. doi: 10.1016/0014-5793(91)80571-j. FEBS Lett. 1991. PMID: 2037066 Free article.

9

Isolation and characterization of biologically active murine interleukin-6 produced in Escherichia coli.

Grenett HE, Danley DE, Strick CA, James LC, Otterness IG, Fuentes N, Nesbitt JE, Fuller GM. Grenett HE, et al. Among authors: otterness ig. Gene. 1991 May 30;101(2):267-71. doi: 10.1016/0378-1119(91)90422-8. Gene. 1991. PMID: 1772482

10

Inhibition of interleukin 1 synthesis by tenidap: a new drug for arthritis.

Otterness IG, Bliven ML, Downs JT, Natoli EJ, Hanson DC. Otterness IG, et al. Cytokine. 1991 Jul;3(4):277-83. doi: 10.1016/1043-4666(91)90495-y. Cytokine. 1991. PMID: 1873477

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters